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Abstract The development of granulomas is a major histo-
pathological feature of tuberculosis. Very little information is
available concerning the physiology and functions of different
celltypesinthe tuberculous granulomas.Theaim of thisstudy
was to compare the epithelioid cells (ECs) and multinucleated
giant cells (MGCs) in the granulomas caused by Mycobacte-
rium tuberculosis complex organisms. Lymph node biopsies
from 30 cases of lymphadenitis were studied for expression
of the secreted mycobacterial protein MPT64, caspase 3 as a
marker of apoptosis, apoptosis-related proteins (Fas Ligand,
Fas and Bax) and inflammatory cytokines (interleukin-10,
transforming growth factor-β (TGF-β), tumour necrosis
factor-α and interferon-γ) by immunohistochemistry. MGCs
more often contained M. tuberculosis secretory antigen
MPT64 (p<0.001) and expressed more TGF-β (p=0.004)
than ECs. The total number of apoptotic MGCs was higher
than the number of apoptotic ECs (p=0.04). Interestingly,
there was a significant negative correlation between apoptosis
and MPT64 expression in MGCs (r=−0.569, p=0.003), but
not in ECs, implying that the heavy antigen load would lead
to inhibition of apoptosis in these cells. When compared with
ECs, higher percentage of MGCs expressed Fas Ligand and
Fas (p<0.004). The role of MGCs may thus be different from
surrounding ECs and these cells by virtue of higher
mycobacterial antigen load, more TGF-β and reduced
apoptosis may contribute towards persistence of infection.
Keywords Epithelioidcells.Multinucleatedgiantcells.
Granulomas.MPT64.Apoptosis.Cytokines.Tuberculosis
Introduction
The development of granulomas in tuberculosis (TB) is an
expression of acquired specific immune response in the
host and is the main histopathological feature of tubercu-
losis. These granulomas are thought to contain the infection
in a localised area, preventing bacterial spread to surround-
ing healthy tissues and to other organs [30, 31]. In humans,
granuloma formation is essential for control of mycobacte-
rial infections, as shown in children where a lack of
granulomatous response is associated with unfavourable
clinical outcome [7]. Immuno-deficient individuals without
interferon (IFN)-γ-induced responses fail to develop gran-
ulomatous structures and subsequently die of mycobacterial
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ble for the typical immunopathology caused by these
infections.
Interleukin (IL)-10, transforming growth factor (TGF)-β,
tumour necrosis factor (TNF)-α and IFN-γ are produced
locally within tuberculous granulomas. In various experi-
mental systems, it has been shown that TNF-α is associated
with activation of macrophages [8] and enhances the
bactericidal activity of monocytes and macrophages togeth-
er with IFN-γ [9]. Both these cytokines are responsible for
granuloma formation [5, 16]. On the other hand, IL-10 and
TGF-β suppress the anti-mycobacterial immune responses
and inhibit macrophage functions resulting in enhanced
intracellular growth of bacteria [4, 13, 21, 34]. These
cytokines by virtue of their anti-inflammatory properties
play a role in limiting the excessive immune response, thus
limiting tissue destruction. An optimal balance between
various cytokines would lead to an effective protective
immune response. Mycobacterium tuberculosis has evolved
strategies to evade killing by the host response and this
can affect the pattern of cytokine secretion in the
granulomas. Pathogenic mycobacteria are shown to inhibit
the apoptosis of the infected cells [15] by influencing the
secretion of apoptosis-related proteins Fas, Fas Ligand
(FasL) [22–24], Bcl2 and Bax [20], which leads to the bac-
terial persistence.
In vitro studies have shown the dynamics of granuloma
formation. M. tuberculosis multiplies within macrophages
and monocytes and the production of cytokines and
chemokines by these infected macrophages induces the
recruitment of macrophages, lymphocytes and dendritic
cells at the infectious site. This cellular accumulation results
in granuloma formation. Within granulomas, macrophages
differentiate into epithelioid cells (ECs) and/or fuse to form
multinucleated giant cells (MGCs), also called Langhans
giant cells [11, 32]. Very little information is available
concerning the physiology of granuloma-specific cell types
such as ECs and MGCs. Are these two cell types different
in their expression of various inflammatory markers and
what role do they play in the host immunity? We have
recently shown that there is a negative correlation between
apoptotic markers and MPT64 expression in tuberculous
granulomas [28]. It has been postulated that granulomas are
responsible for the persistence of bacilli, but which cell
types in the granulomas contribute towards this is not
known.
The specific aim of this study was to compare the ECs
and MGCs in the lesions caused by M. tuberculosis with
respect to the expression of secreted mycobacterial protein
MPT64 as a marker for mycobacterial infection, expression
of caspase 3 as a marker of apoptosis, apoptosis-related
proteins (FasL, Fas and Bax) and inflammatory cytokines
(IL-10, TGF-β, TNF-α and IFN-γ).
Material and methods
Lymph node biopsies from 30 cases of tuberculous
lymphadenitis were studied. Seventeen cases were obtained
from the archives of Department of Pathology, Haukeland
University Hospital, Norway. Thirteen cases were from
patients diagnosed with mycobacterial lymphadenitis in an
epidemiological study from rural Tanzania [19]. All these
cases were confirmed to be caused by M. tuberculosis
complex organisms based on the polymerase chain reaction
done for amplification of IS6110 as described earlier [27].
All the cases were studied for the expression of mycobac-
terial antigen, apoptosis and all the proteins except Bax
which was studied in 13 Tanzanian cases only. Ethical
clearance was obtained from the Medical Research Co-
ordinating Committee in Tanzania and the regional ethical
committee in Norway. All participants from Tanzania gave
verbal consent to the study.
Histology and immunohistochemistry
Parallel 5-µm-thick sections from each specimen were
stained with haematoxylin and eosin, and immunostaining
was done as described previously [25]. A kit (EnVision+
System-HRP) was used for immunostaining (DakoCytoma-
tion Denmark A/S, Glostrup, Denmark). Briefly, after
deparaffinisation and rehydration, the sections were exposed
to microwave antigen retrieval using citrate buffer pH 6.0 at
750 W for 10 min and at 350 W for 15 min. The sections
were cooled for 20 min at room temperature and then
incubated with H2O2 solution for 5 min. Primary antibodies
were then applied to the sections for 45 min followed by
incubation for 40 min with anti-rabbit or anti-mouse
immunoglobulin conjugated with dextran polymer and
horseradish peroxidase. The visualisation was with 3-amino-
9-ethylcarbazol containing H2O2 (for cytokines and caspase
3) or diaminobenzidine for 10 min (for apoptosis-related
proteins).
The following primary antibodies were used: MPT64
was detected using in-house-raised polyclonal rabbit anti-
bodies [27]. Apoptotic cells were detected by caspase 3
staining (R&D Systems, Abingdon, Oxon, UK). IL-10,
TNF-α and IFN-γ were detected with antibodies from
ImmunoTools, Friesoythe, Germany, TGF-β with anti-
bodies from Santa Cruz Biotechnology, Santa Cruz, CA,
USA. Apoptosis-related protein FasL with antibodies from
Alexis Biochemicals, San Diego, CA, USA, Fas, Bax and
Bcl-2 with antibodies from Santa Cruz Biotechnology,
Santa Cruz, California, USA. All of the antibodies were
mouse monoclonal antibodies except anti-TGF-β, and anti-
caspase-3 which were rabbit polyclonal antibodies as
described previously [25].
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analysis
The percentage of stained ECs was calculated by counting
stained cells and the total number of nucleated cells in two
to three areas from each biopsy, using a ×40 ocular fitted
with a 10×10-mm grid. All the stained cells, irrespective of
staining intensity, were counted. On average, 334 nucleated
cells were present in one field–grid. For MGCs, the whole
section was studied and all the MGCs were counted. Data
were presented as a percentage of the stained MGCs. The
number of MGCs varied in the biopsies ranging from 2 to
42 (median=15) MGCs. Non-parametric Wilcoxon signed-
rank sum test for related samples was used for comparison
of ECs and MGCs. Linear regression was performed to
determine the relationship between the number of apoptotic
cells and cells containing mycobacterial antigen. Bivariate
correlations between number of cells stained for various
proteins was determined by Spearman’s rank correlations.
p values less than 0.05 were considered as significant.
Results
Morphology
All the biopsies had necrotic granulomas. In 11 cases, there
were additional non-necrotic granulomas. The morphology
of MGCs varied. Some cells were relatively small with four
to five nuclei in the centre of the cell, while others were large
cells with many nuclei forming a ring in the cytoplasm. Both
types of cells could be present in the same biopsy.
Fig. 1 a–b Percentage of epi-
thelioid cells (ECs) and multi-
nucleated giant cells (MGCs)
expressing MPT64 antigen (a),
and caspase 3 for apoptotic cells
(b) detected by immunohisto-
chemical staining in the lymph-
adenitis granulomas caused by
M. tuberculosis (n=30). The
median, 25th and 75th percen-
tiles and minimum and maxi-
mum values are shown. The
marks filled circle indicate the
outliers. The statistically signif-
icant results are marked with p
values. c–d Linear regression
was performed to determine the
relationship between apoptotic
ECs and the MPT64-antigen-
containing ECs (c),
and apoptotic MGCs and
MPT64-antigen-containing
MGCs (d) among the tubercu-
lous granulomas. There was a
significant negative correlation
between apoptotic MGCs and
MPT64-antigen-containing
MGCs
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with apoptotic MGCs
MPT64 was expressed in the ECs and MGCs in the
granulomas. Figure 1a shows the number of ECs and MGCs
expressing MPT64 antigen. A higher proportion of MGCs
(median=33%) expressed MPT64 antigen as compared to
the ECs (median=2.1%, p<0.001). The intensity of staining
in ECs and MGCs varied from weak to strong, indicating
variation in the amount of antigen present in individual cells.
Figure 2 shows granuloma cells with strong expression of
MPT64 antigen.
Expression of caspase 3 was used to detect the apoptotic
cells. Both ECs and MGCs in the granulomas expressed
caspase 3 as shown in Fig. 2. Figure 1b shows the number
of ECs and MGCs expressing this protein. The numbers of
apoptotic ECs (median=17%) were lower than the apopto-
tic MGCs (median=27.5%, p=0.04). Interestingly, there
was a significant negative correlation between the apoptotic
MGCs and the MPT64 expressing MGCs (r=−0.569, p=
0.003), while no significant correlation was found between
apoptotic ECs and MPT64 expressing ECs (Fig. 1c–d),
implying that the heavy antigen load would lead to
inhibition of apoptosis in these cells.
MGCs express more FasL and Fas than ECs
Both the ECs and MGCs expressed FasL, Fas and Bax
(Fig. 2). Figure 3a shows the number of these cells
expressing the proteins. When compared with ECs, higher
percentage of MGCs expressed FasL (median; EC=23.3%,
MGC=45.7%, p=0.008) and Fas (median; EC=15.3%,
MGC=44%, p=0.005). Table 1 shows the correlation
between the numbers of ECs and MGCs expressing
different proteins. The relationship of these proteins was
different between the ECs and MGCs. FasL-expressing
ECs correlated positively with Fas- (p<0.001) and Bax-
expressing (p<0.05) ECs, and Fas-expressing ECs correlated
Fig. 2 Lymph node tissues
showing the staining pattern of
epithelioid cells and multinucle-
ated giant cells in the tuberculous
granulomas for mycobacterial
secretory antigen MPT64, cas-
pase 3 for detection of apoptotic
cells, apoptosis-related proteins
and cytokines, as detected by
immunohistochemical staining
452 Virchows Arch (2008) 452:449–456positively with Bax-expressing ECs (p<0.05). While among
MGCs, FasL-expressing MGCs correlated positively with
TGF-β-a n dI F N - γ-expressing MGCs, and Fas-expressing
MGCs correlated positively with IL-10-expressing MGCs
(p<0.05). Fas- and Bax-expressing ECs and MGCs corre-
lated positively (p<0.001).
MGCs express more TGF-β than the ECs
Among the pro- and anti-inflammatory cytokines, ECs and
MGCs expressed IL-10, TGF-β,T N F - α and IFN-γ
(Fig. 2). Figure 3b shows the numbers of cells expressing
these cytokines. Higher number of MGCs expressed TGF-β
as compared with ECs (median; MGC=60.5%, EC=24.5%,
p=0.004), while there was no statistically significant
difference between the number of two cell types expressing
IL-10, TNF-α or IFN-γ. The intensity of staining of IFN-γ
was, however, stronger in the ECs than in the MGCs
(Fig. 2), but the cell counts represent all stained cells
irrespective of staining intensity. The number of TGF-β-
expressing MGCs were higher than the numbers of IFN-γ-
(median=0%, p=0.004) and TNF-α-expressing (median=
18%, p=0.01) MGCs (p<0.01), while numbers of TGF-β-
expressing ECs were lower than TNF-α- (median=59.5%,
p<0.001) and IL-10-expressing (median=47.9%, p=0.01)
ECs. The correlation between the numbers of ECs and
MGCs expressing different proteins is shown in Table 1.T h e
numbers of TGF-β-expressing ECs correlated positively
with the numbers of IL-10- (p<0.05) and TNF-α-expressing
(p<0.001) ECs, while the numbers of TGF-β-expressing
MGCs correlated positively with IFN-γ-expressing MGCs
(p<0.05). IL-10- and TNF-α-expressing MGCs also corre-
lated positively (p<0.001).
Discussion
The differential expression of mycobacterial antigens,
inflammatory and apoptosis markers by the ECs and MGCs
suggests different functions of the two cell types. The ECs
seem to have better mycobactericidal functions and conse-
quently have lesser antigen load as determined by MPT64
expression. When these cells mature into MGCs, the
expression of TGF-β increases which can lead to reduced
mycobactericidal capability. Consequently, these cells carry
a higher antigen load than the ECs. This transition in the
pattern of cytokine expression can be attributed to the
interaction of M. tuberculosis with the host cells to avoid
killing by the host cells.
Both ECs and MGCs expressed caspase 3, which
suggest that these cells are removed by apoptosis. This is
in agreement with the observations that activated immune
cells are eliminated by apoptosis which limits their
destructive potential. However, the number of apoptotic
MGCs and the MGCs with MPT64 antigen were higher
than the respective ECs. Based on these findings, it can be
hypothesised that the ECs which contain mycobacterial
antigens may avoid apoptosis and preferentially fuse to
form MGCs, while those without mycobacteria or its
components are removed by apoptosis. The negative
correlation of MPT64-antigen-expressing MGCs with the
apoptotic MGCs implies that those with the most antigens
may resist apoptosis. This is in agreement with studies
showing that virulent mycobacteria cause inhibition of
Fig. 3 Percentage of epithelioid cells and multinucleated giant
cells expressing apoptosis-related proteins (a) and cytokines (b)i n
the lymphadenitis granulomas caused by M. tuberculosis, detected by
immunohistochemical staining. The median, 25th and 75th percentiles
and minimum and maximum values are shown. The marks filled
circles indicate the outliers. The statistically significant results are
marked with p values
Virchows Arch (2008) 452:449–456 453apoptosis and use these cells as a sanctuary to avoid
immune response and persist in the host [15, 20, 22]. These
MGCs may then prevent the granulomas to regress and
heal, by antigen presentation to the surrounding lympho-
cytes and continuous recruitment of new cells. These
suggestions are supported by findings from a previous
work where an in vitro model of granulomas showed that
only virulent species of the M. tuberculosis complex
triggered the formation of MGCs, resembling natural
Langhans giant cells found in human tuberculous granulo-
mas [17]. These large MGCs are as active as macrophages,
but they have reduced capacity of phagocytosis, despite a
conserved ability to mediate antigen presentation.
Antigen-presenting cells with increased expression of
FasL are shown to induce apoptosis in T-cells during
antigen presentation, thus inducing antigen-specific T-cell
tolerance [35]. In this study, more MGCs expressed FasL
than ECs, and FasL-expressing MGCs correlated positively
with TGF-β-expressing MGCs. As the infected MGCs are
s h o w nt op o s s e s sa n t i g e np r e s e n t a t i o nc a p a b i l i t yb y
expression of major histocompatibility complex class II
receptors [17], it can be assumed that FasL-expressing
MGCs may lead to death of a subset of M. tuberculosis-
specific T-cells, causing specific immune suppression in the
host. This hypothesis is indirectly supported by studies in
tuberculosis patients where constant apoptosis of T-cells
has been shown to result in a reduction in T-cell numbers
and depressed proliferative responses [14, 18]. Further-
more, the observation that FasL-expressing ECs correlate
positively with Fas-expressing ECs while no significant
correlation was found between these proteins among MGCs
suggests that MGCs with increased expression of FasL do
not simultaneously express Fas, which would help these
cells to evade being killed via Fas–FasL pathway.
MPT64 is a 26-KD secreted mycobacterial protein
shown to be specific for M. tuberculosis complex organ-
isms [6, 12]. Secreted mycobacterial proteins are consid-
ered immunodominant and are involved in inducing
protective immunity [1], but little is known about the role
of MPT64 in host immunity. This antigen has been detected
in the macrophages of human and mouse TB lesions [26,
27] and elicits T-cell responses in patients infected with TB
[29]. The region encoding the corresponding mpb64 gene is
deleted from several bacillus Calmette–Guerin strains, and
this has been correlated with a drop in virulence in animal
infection models and reduced vaccine lesions in humans
[2], suggesting a role of MPT64 in mycobacterial virulence.
In this study, increased expression of MPT64 and TGF-β,
FasL and Fas in MGCs as compared to ECs and a negative
correlation between MPT64 expression and apoptosis in
MGCs suggests that MPT64 may induce an increased
expression of these proteins and inhibition of apoptosis of
infected MGCs, making them more suitable for mycobac-
terial survival. There was, however, no significant correla-
tion between MGCs expressing MPT64 and these proteins,
and further studies are required to investigate the role of
MPT64 in disease pathogenesis.
The difference in the pattern of relationship of cytokines
between ECs and MGCs suggests different roles of these
two cell types for control of the infection. Paradoxically, the
number of MGCs expressing anti-inflammatory cytokines
TGF-β and IL-10 correlated positively with MGCs
Table 1 Relationship between the numbers of epithelioid cells and multinucleated giant cells expressing caspase 3, apoptosis-related proteins and
various cytokines in granulomas caused by M. tuberculosis based on Spearman’s rank correlation
EC MGC
Fas Bax IL-10 TNF-α TGF-β IFN-γ FasL Fas Bax IL-10 TNF-α TGF-β IFN-γ
EC
FasL 0.7* 0.59** −0.25 −0.17 −0.06 −0.30 0.24
Fas 0.58** −0.30 −0.37 −0.35 −0.31 0.64*
Bax −0.13 0.08 0.17 −0.07 0.85*
IL-10 0.30 0.39** 0.05 0.16
TNF-α 0.67* 0.22 −0.15
TGF-β 0.12 0.26
IFN-γ 0.26
MGC
FasL 0.38 0.22 −0.02 0.15 0.55** 0.57**
Fas 0.45 0.51** 0.29 0.11 −0.07
Bax 0.24 0.29 0.07 0.20
IL-10 0.68* 0.08 −0.09
TNF-α 0.26 0.28
TGF-β 0.49**
The values shown are the correlation coefficients.
*p<0.001; **p<0.05
454 Virchows Arch (2008) 452:449–456expressing pro-inflammatory cytokines IFN-γ and TNF-α,
respectively. However, the intensity of staining for IFN-γ
was less than TGF-β in MGCs as shown in Fig. 2, which
may imply a reduced amount of IFN-γ as compared to
TGF-β in these cells, while this difference in intensity was
not reflected in the cell counts. Furthermore, TGF-β can
block the mycobactericidal mechanisms induced by IFN-γ
[33], and IL-10 has been shown to block the activity of
TNF-α by inducing the release of soluble TNF-α receptor
type 2 (TNFR2) from macrophages and the formation of
inactive TNF-α-TNFR2 complexes [10]. These observa-
tions suggest that MGCs by virtue of increased levels of anti-
inflammatory cytokines favour mycobacterial persistence.
In conclusion, we have found that a higher number of
MGCs contain M. tuberculosis secretory antigen MPT64
and express more TGF-β as compared to ECs, implying that
the maturation of ECs into MGCs is associated with
reduction in mycobactericidal function which can lead to
accumulation of mycobacterial antigen. The negative corre-
lation between MPT64 in MGCs and caspase-3-expressing
MGCs suggests that the infected MGCs avoid apoptosis.
The MGCs and ECs may thus play different roles, EC being
more fit to eliminate the bacilli, while MGCs harbour them.
The relationship between these cells needs further analysis.
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